Ownership and insider activity for None (SRTS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy.
Price
| Price | $3.07 |
| Market Cap | $51M |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-31 | Sachetta Eric | P-Purchase | 27,304 | $97K |
| 2026-08-28 | Sachetta Eric | P-Purchase | 37,537 | $129K |
| 2026-08-27 | Sachetta Eric | P-Purchase | 10,925 | $35K |
| 2026-08-26 | Sachetta Eric | P-Purchase | 9,708 | $32K |
| 2026-08-24 | Sachetta Eric | P-Purchase | 34,697 | $113K |
| 2026-08-20 | Sardano Joseph C | P-Purchase | 20,000 | $60K |
| 2026-08-21 | Sachetta Eric | P-Purchase | 7,000 | $23K |
| 2026-08-20 | Sachetta Eric | P-Purchase | 24,000 | $75K |
| 2026-05-12 | Sachetta Eric | P-Purchase | 1,500 | $5K |
| 2025-11-13 | Sachetta Eric |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.0M | $10.1M | $12.5M | $8.1M | $14.9M | $14.5M | $25.5M | $23.1M | $22.1M | $22.1M |
| Short-term Investments | $6.5M | $1.1M | $2.9M | $7.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $3.1M | $5.0M | $13.1M | $14.0M | $3.8M | $12.1M | $17.3M | $10.6M | $19.7M | $6.0M |
| Inventory | $1.3M | $1.2M | $1.6M | $3.0M | $4.4M | $1.8M | $3.5M | $11.9M | $10.1M | $14.6M |
| Total Current Assets | $16.8M | $17.9M | $31.9M | $34.0M | $25.2M | $31.2M | $53.2M | $49.5M | $56.7M | $45.9M |
| Property, Plant & Equipment | $433408 | $394078 | $891029 | $2.5M | $2.4M | $774000 | $1.2M | $1.2M | $2.6M | $2.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $626509 | $530123 | $433737 | $337351 | $338000 | $146000 | $50000 | 0 | 0 | 0 |
| Total Assets | $18.9M | $18.8M | $33.3M | $36.9M | $28.0M | $32.2M | $56.7M | $53.7M | $62.2M | $53.0M |
| Accounts Payable | $2.8M | $4.1M | $5.2M | 0 | 0 | $4.1M | $5.5M | $2.8M | $4.8M | $3.3M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | $51000 | 0 | 0 | 0 | $262000 |
| Total Current Liabilities | $3.7M | $7.1M | $6.0M | $6.5M | $4.9M | $6.0M | $7.7M | $4.2M | $5.9M | $4.7M |
| Long-term Debt | 0 | $2.2M | 0 | 0 | $267000 | 0 | 0 | 0 | 0 | $209000 |
| Total Liabilities | $3.7M | $7.2M | $6.8M | $8.9M | $6.5M | $6.2M | $8.7M | $4.9M | $6.3M | $4.9M |
| Retained Earnings | -$7.8M | -$11.5M | -$13.5M | -$15.2M | -$22.1M | -$17.9M | $6.3M | $6.8M | $13.4M | $5.7M |
| Total Equity | $15.3M | $11.7M | $26.5M | $28.0M | $21.5M | $26.0M | $48.1M | $48.8M | $55.8M | $48.1M |
| Total Debt | 0 | $2.2M | 0 | $1.4M | $1.4M | $225000 | $1.0M | $783000 | $602000 | $680000 |
| Net Debt | -$11.5M | -$9.0M | -$15.4M | -$14.1M | -$13.5M | -$14.3M | -$24.5M | -$22.4M | -$21.5M | -$21.4M |
| Working Capital | $13.1M | $10.8M | $25.9M | $27.5M | $20.3M | $25.3M | $45.5M | $45.3M | $50.9M | $41.2M |
Financial Health
| Piotroski F-Score | 3 |
| Altman Z-Score | 8.85 |
Related companies: BDMD · CTSO · ICCM · IPSC · KPTI · MDAI · MDCX
More sections of SRTS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks